FDA de­nies Ipsen's cit­i­zen pe­ti­tion for block­buster drug So­mat­u­line

US drug reg­u­la­tors have turned down Ipsen’s ef­fort to slow down gener­ic com­pe­ti­tion for its block­buster drug So­mat­u­line De­pot, which is used to slow the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.